Increased risk weighs on MITRA KELUARGA KYST., penalising its rating down to Slightly Negative
The independent financial analyst theScreener just lowered the general evaluation of MITRA KELUARGA KYST. (ID), active in the Health Care Providers industry. As regards its fundamental valuation, the title still shows 0 out of 4 possible stars. Its market behaviour, however, has slightly deteriorated and will be qualified as moderately risky moving forward. theScreener considers that these new qualifications justify an overall rating downgrade to Slightly Negative. As of the analysis date January 25, 2022, the closing price was IDR 2,210.00 and its target price was estimated at IDR 1,910.48.PT Mitra Keluarga Karyasehat Tbk is an Indonesia-based company primarily engaged in operating a private hospital group. The hospitals are operated under the brand name Rumah Sakit Mitra Keluarga. Its hospitals offers a range of specialist medical services, including complex surgical procedures, radiology and imaging facilities, fertility treatment as well as general healthcare, diagnostic and emergency services. Its hospitals are located in various areas in Indonesia, including Bekasi, Jakarta, Surabaya, Depok, Tegal and Sidoarjo.
Empowering Investors
theScreener is the market leader for independent valuations of financial securities, equities, sectors and markets, and new funds. theScreener's ratings, analyses are used by leading banks, asset managers and financial portals. Approximately 10,000 workstations benefit from theScreener's services, with over millions of customer accounts actively analysed.
- Worldwide coverage: theScreener analyses cover around 6'500 Stocks, i.e 95% of the world Market Capitalization. theScreener state of art: We provide
- theScreener state of art: We provide easy to use and complete analyses over Stocks, including Fundamentals / Technical / Risk/ Peer / Alternatives analyses.
- For Research Pool community, we provide twice a week around 500 new equity analyses. We produce analyses about equities which have been upgraded or downgraded.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.